A research team of ICMAB-CSIC scientists, with the participation of researchers from IBEC and universities UPC and UIC Barcelona, manages to scale-up biohybrid hydrogel matrices that improve the proliferation of human T-cells in cultures, moving closer to bringing the technique out of the laboratory.
Nowadays, the method used to obtain the immune cells needed for these therapies consists of culturing the cells in liquid suspension. In previous studies, researchers from ICMAB had already proposed to add a matrix that reproduces the lymph nodes in the body, where the activation of T-cells normally occurs, as there is growing evidence about the influence of this immune microenvironment on the resulting cell products. In the multitude of natural and synthetic hydrogels used to replicate the matrix, polyethylene glycol (PEG)-heparin hydrogels have shown to enhance the human T-cell proliferation.
Reference:
3D Printing as a Strategy to Scale-Up Biohybrid Hydrogels for T Cell Manufacture
Eduardo Pérez Del Río, Sergi Rey-Vinolas, Fabião Santos, Miquel Castellote-Borrell, Francesca Merlina, Jaume Veciana, Imma Ratera, Miguel A. Mateos-Timoneda, Elisabeth Engel*, and Judith Guasch*.
ACS Applied Materials & Interfaces Article ASAP
DOI: 10.1021/acsami.4c06183
Links:
El Pou - Ràdio Sant Cugat: https://www.cugat.cat/diari/sons/169056/la-proliferacio-de-cellules-amb-un-sistema-d_impressio-3d-per-combatre-el-cancer_-al-podcast-_el-pou_
Nota de premsa (CAT): Síntesi a gran escala de cèl·lules per combatre el càncer mitjançant hidrogels biohíbrids i impressió 3D
Nota de prensa (CAST): Síntesis a gran escala de células para combatir el cáncer mediante hidrogeles biohíbridos e impresión 3D
Press release (ENG): Biohybrid hydrogels and 3D printing to synthesize large amounts of cells used against cancer